Skip to main content
. 2019 Jul 10;15(1):60–66. doi: 10.1159/000501498

Table 1.

Baseline characteristics of the 21 eligible studies included in this review

First author [ref.], year Patients, n Age, yearsa Methodology Follow-up perioda Jadad score
Li [8], 2018 75 35.84±9.98 (21–61) surgery/steroids/antibiotics 12 (1–60)c 5
Shin [3], 2017 34 37 (24–47) surgery/steroids/antibiotics/observation 45.5 (22–98)c 4
Akahane [15], 2013 12 36 (25–47) surgery/steroids 22 (6–104)c 5
Hovanessian Larsen [10], 2009 54 33.1 (22–44) surgery/steroids/antibiotics/observation NA (3–27c) 5
Gurleyik [4], 2012 19 34.1 (27–59) surgery/steroids 20 (6–75)c 3
Néel [17], 2013 23 39 (25–61) surgery/steroids/antibiotics 75c (14c−28b) 4
Akcan [18], 2014 74 34.8±11.7 surgery/steroids 41 (3–170)c 5
Gunduz [1], 2014 11 35 (24–46) steroids 17 (12–48)c 4
Karanlik [19], 2014 37 34 (23–57) surgery/steroids/observation 38 (22–78)c 5
Kiyak [20], 2014 24 38.4 (28–60) surgery 34.8 (10–66)c 5
Pandey [6], 2014 49 35 (24–67) surgery/steroids/observation NA (6–12c) 4
Aghajanzadeh [9], 2015 206 32 (22–40) surgery/steroids/antibiotics NA (9–18c) 4
Altintoprak [16], 2015 52 35.7 (24–48) surgery/steroids/antibiotics 37.2 (12–72)c 4
Bouton [21], 2015 37 33 (22–46) surgery/antibiotics/observation 7.4 (0–20)c 5
Mahlab-Guri [12], 2015 17 44.6±12.6 (30–72) antibiotics/observation 4.7±3.8 (0.5–13)b 3
Sheybani [7], 2015 22 32.8±6.2 (23–47) steroid/MTX 11.96±4.4 (6–22)c 4
Yabanoğlu [22], 2015 77 36 (28–68) surgery/steroids 18 (1–120)c 5
Sakurai [23], 2011 8 44.8 (28–75) surgery/steroids/antibiotics 40.3 (14–67)c 2
Hur [11], 2013 50 37.1±7.9 surgery/steroids/antibiotics NA (32.0±18.1c) 3
Kok and Telisinghe [24], 2010 43 34 surgery/steroids 15 (1–80)c 2
Oran [25], 2013 46 33 (28–55) surgery/steroids 35.4 (3–135)c 4

NA, not available.

a

Age and follow-up period were presented as median (range) or average (mean ± SD) and/or range in parentheses in different studies.

b

Years.

c

Months.